Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.
Yu JJ, Robb VA, Morrison TA, Ariazi EA, Karbowniczek M, Astrinidis A, Wang C, Hernandez-Cuebas L, Seeholzer LF, Nicolas E, Hensley H, Jordan VC, Walker CL, Henske EP
Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells
Proceedings of the National Academy of Sciences of the United States of America (2009) 106:2635-2640.
Lymphangioleiomyomatosis (LAM) is an often fatal disease primarily affecting young women in which tuberin (TSC2)-null cells metastasize to the lungs. The mechanisms underlying the striking female predominance of LAM are unknown. We report here that 17-beta-estradiol (E-2) causes a 3- to 5-fold increase in pulmonary metastases in male and female mice, respectively, and a striking increase in circulating tumor cells in mice bearing tuberin-null xenograft tumors. E-2-induced metastasis is associated with activation of p42/44 MAPK and is completely inhibited by treatment with the MEK1/2 inhibitor, CI-1040. In vitro, E-2 inhibits anoikis of tuberin-null cells. Finally, using a bioluminescence approach, we found that E-2 enhances the survival and lung colonization of intravenously injected tuberin-null cells by 3-fold, which is blocked by treatment with CI-1040. Taken together these results reveal a new model for LAM pathogenesis in which activation of MEK-dependent pathways by E-2 leads to pulmonary metastasis via enhanced survival of detached tuberin-null cells.
Publication Date: 2009-02-01.
PMCID: PMC 2637277
Last updated on Tuesday, August 04, 2020